100 results
Page 3 of 5
8-K
EX-99.1
7yihxvdln8j1 66x
6 May 22
Akero Therapeutics Reports First Quarter 2022 Financial Results
7:26am
8-K
EX-99.1
uq4wt2euwrne
25 Feb 22
Akero Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
7:15am
8-K
EX-99.1
nalw31omegg9d 2cz5
12 Nov 21
Regulation FD Disclosure
8:08am
8-K
ruh7tf
12 Nov 21
Regulation FD Disclosure
8:08am
8-K
EX-99.1
drvl8gj xrj
12 Nov 21
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
7:06am
8-K
EX-99.1
mjm43bc2
13 Aug 21
Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
7:04am
8-K
EX-99.1
klk7op
25 Jun 21
Regulation FD Disclosure
4:51pm
8-K
cfm dakbvq504hi
25 Jun 21
Regulation FD Disclosure
4:51pm
8-K
EX-99.1
nb4zjy u174r
21 Jun 21
Regulation FD Disclosure
8:15am
8-K
9yf1b3t ul
21 Jun 21
Regulation FD Disclosure
8:15am
8-K
EX-99.1
nqcoodvy
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
6eej0e
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.2
ab8jxfpe89bi4 abl
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm